Atezolizumab Combined With Immunogenic Chemotherapy in Patients With Metastatic Triple-negative Breast Cancer

NCT03164993 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Cancer, Breast
Triple Negative Breast Cancer

Interventions

DRUG: Atezolizumab
DRUG: Pegylated liposomal doxorubicin
DRUG: Cyclophosphamide
OTHER: Placebo

Sponsor

Oslo University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]